spacer
home > ebr > summer 2008 > dealing with the deluge
PUBLICATIONS
European Biopharmaceutical Review

Dealing with the Deluge

Flow cytometry is a technique for cell characterisation that is popularly used in basic and translational research for understanding, for example, how mutated stem cells may confer therapy resistance to a tumour (1). Alternatively, cell characterisation can be used to measure cell receptors during activation or as a response to immunosuppressive drugs. A flow cytometer consists of a narrow, hydrodynamically-focused stream of cells that pass and are interrogated by a light source. The cellsí physical characteristics of size and granularity, as well as any fluorescent labels attached in or on the cells, scatter the beam of light. Fluorescent labels attached will then be excited, enabling the appropriate emission characteristics to be measured in relative terms of fluorescent intensity.

Flow cytometer manufacturers have responded to the needs of modern researchers by developing faster systems that can measure more variables over shorter time periods for applications such as detecting tumour cells in peripheral blood and examining different aspects of stem cell differentiation. However, the ability of the software that flow cytometers rely on to analyse and visualise the rapidly rising tide of data now being generated has lagged way behind these improvements in instrument technology. This article examines some of the approaches that enlightened software manufacturers are now taking to speed up and simplify data analysis and support the revolution in flow cytometry research.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gillian Byrne is the Product Specialist of Applied Cytometry. Gillianís responsibilities include establishing and maintaining expert technical knowledge of the companyís products and determining the market needs for effective product launch strategies. She plays an active role in developing business relationships with customers of the flow cytometry industry as well as displaying her expert product knowledge at global industry related events. As a biomedical science graduate, Gillianís career was mainly spent in the public sector before venturing into the private sector, working as a state registered biomedical scientist for a clinical microbiology laboratory. Here she gained valuable skills in all aspects of bacteriology, serology and molecular biology, giving her first hand experience of the biomedical industry.
spacer
Gillian Byrne
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nanobiotix presents NBTXR3 preclinical data


More info >>

White Papers

Pharmaceutical Companies: Outsourcing Combination Product Manufacturing

Phillips-Medisize

Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
More info >>

 
Industry Events

Clinical Trial Supply West Coast conference 2017

24-25 May 2017, Burlingame, California

Clinical Trial Supply West Coast returns in 2017 this time in Burlingame. Attracting the leading biotech and pharma companies from Northern California and beyond, the event will focus on how drug companies can adapt their supply chains to fit into the highly regulated world. For the first time key topics will be explored through Debates, Workshops and extended Roundtable discussions. With standout presenters from Sanofi, Genentech, Dynavax and Gilead, this is an event not to miss out on Ė reserve your place today!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement